Tabby Therapeutics, co-founded by Arkin Bio, is developing engineered B cell therapies that target solid tumors and elicit a multi-modal immune response.
Arkin Entry Stage
Discovery
Status
Active
Location
Boston, MA
Let’s get in touch!
